# enGene Therapeutics Inc.: Form 8-K, filed Aug 11, 2026

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 16:03 ET
- Period: 2026-08-11
- Accession: 0001193125-26-344559
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000119312526344559/engn-20260811.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000119312526344559/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000119312526344559/engn-20260811.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-344559. Last ingested by Listed: Nov 14, 2026, 22:37 ET. No prices; not investment advice.